| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,553 | 2,248 | 2,779 | 1,313 | | Cost of Revenue | 1,576 | 1,519 | 1,642 | 733 | | | Gross Profit | 977 | 729 | 1,137 | 579 | | | Operating Expenses | | Research Development | 61 | 75 | 87 | 110 | | Selling General and Administrative | 1,437 | 1,181 | 1,522 | 1,603 | | Non Recurring |
-
|
-
|
-
| 506 | | Others | 513 | 324 | 323 | 367 | | | | Total Operating Expenses |
-
|
-
|
-
| 2,586 | | | | Operating Income or Loss | (845) | (850) | (796) | (2,007) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17 | 12 |
-
| (42) | | Earnings Before Interest And Taxes | (1,017) | (838) | (796) | (2,049) | | Interest Expense | (67) | 132 | 142 | 49 | | Income Before Tax | (950) | (970) | (939) | (2,098) | | Income Tax Expense | 5 | 5 | 5 | 5 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (955) | (975) | (944) | (2,103) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (955) | (975) | (944) | (2,103) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($955) | ($975) | ($944) | ($2,103) |
|
0.03% Nasdaq 
0.02 (0.82%) 
Income Statement
